NPI: 1841253176 · PHILADELPHIA, PA 19104 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/08/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/08/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 22,176 | $2K |
| 2020 | 1,517 | $105K |
| 2021 | 5,052 | $477K |
| 2022 | 3,122 | $533K |
| 2023 | 3,763 | $350K |
| 2024 | 4,026 | $354K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 18,542 | 1,504 | $1.82M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 8,198 | 425 | $2K |
| A4657 | Syringe, with or without needle, each | 1,039 | 698 | $0.00 |
| J1270 | Injection, doxercalciferol, 1 mcg | 4,737 | 409 | $0.00 |
| 82728 | 422 | 404 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 105 | 84 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 42 | 42 | $0.00 |
| 82607 | 34 | 34 | $0.00 | |
| 83550 | 231 | 211 | $0.00 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 19 | 13 | $0.00 |
| 90674 | 14 | 14 | $0.00 | |
| 85041 | 415 | 389 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 1,750 | 497 | $0.00 |
| 85048 | 415 | 389 | $0.00 | |
| 83970 | 599 | 567 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 250 | 146 | $0.00 |
| 83540 | 426 | 405 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 2,156 | 183 | $0.00 |
| 82108 | 48 | 47 | $0.00 | |
| 84466 | 201 | 199 | $0.00 | |
| 90662 | 13 | 13 | $0.00 |